🇺🇸 FDA
Patent

US 7829723

Polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-3-(3-methoxy-4-(oxazol-5-yl)phenyl)uriedo)phenyl)ethylcarbamate

granted A61PA61P1/02A61P1/04

Quick answer

US patent 7829723 (Polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-3-(3-methoxy-4-(oxazol-5-yl)phenyl)uriedo)phenyl)ethylcarbamate) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P1/02, A61P1/04, A61P1/18, A61P11/00